相关实验视频

Updated: Jun 23, 2025

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

诱导多能干细胞和CRISPR-Cas9创新用于治疗α-1抗素缺乏症和糖原储存疾病

Colin Walsh¹, Sha Jin¹

¹Department of Biomedical Engineering, Thomas J. Watson College of Engineering and Applied Sciences, State University of New York at Binghamton, Binghamton, NY 13902, USA.

|June 26, 2024

概括

人类诱导的多能干细胞 (iPSC) 和CRISPR-Cas9基因编辑为模拟和治疗A1AD和GSD等遗传疾病提供了强大的新方法. 这些技术推动了精准医学和对代谢和遗传疾病的药物发现.

科学领域:

生物技术是生物技术.
遗传学是一个遗传学.
再生医学是一种再生医学.

背景情况:

人类诱导的多能干细胞 (iPSC) 和CRISPR-Cas9基因编辑正在彻底改变疾病研究.
代谢和遗传性疾病,如α-1抗素缺乏症 (A1AD) 和糖原储存疾病 (GSD),存在重大临床挑战,特别是影响肝脏和肺部健康.

研究的目的:

为研究人员和临床医生提供关于iPSC和CRISPR-Cas9在治疗代谢和遗传疾病中的应用的最新理解.
突出iPSCs用于病理建模和药物发现的潜力,以及CRISPR-Cas9用于精确的基因校正.
检查这些技术在应对A1AD和GSD等特定疾病中的作用.

主要方法:

审查关于iPSC技术和CRISPR-Cas9基因编辑的当前文献.
分析疾病建模,药理测试和代谢和遗传障碍的治疗开发中的应用.
讨论成就,挑战 (技术,道德,监管) 和未来的方向.

主要成果:

iPSCs作为一个独特的平台,用于详细的疾病建模和药物查.
克里斯普尔-Cas9可实现精确的基因校正,提供超出症状管理的潜在治疗策略.
在将这些技术应用于A1AD和GSD等疾病方面取得了重大进展.

结论:

iPSC 技术和 CRISPR-Cas9 基因编辑是代谢和遗传疾病的转变工具.
对基因编辑精度和传递系统的持续创新对于下一代治疗非常重要.
解决技术,伦理和监管方面的挑战对于临床翻译至关重要.

关键词:

克里斯普尔-Cas9是什么意思阿尔法-1抗素缺乏症基因治疗的基因疗法糖原储存疾病糖原储存疾病诱导多能干细胞的诱导干细胞.代谢障碍代谢障碍代谢障碍治疗建模治疗建模

更多相关视频

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

Published on: March 5, 2017

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells

Published on: September 25, 2019

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...

What is Genetic Engineering?

What is Genetic Engineering?